Leerink Partners Cuts Price Target on TeamHealth Holdings (TMH) After Meeting with Management
- Stocks dip as earnings pour in, consumer discretionary lags
- UPDATE: Alphabet (GOOG) Tops Q3 EPS Views; Revs Strong
- Baker Hughes (BHI), General Electric (GE) in Partnership Talks, Not Merger Talks
- Cirrus Logic, Inc. (CRUS) Q2 Results and Guidance Beat Estimates
- Amazon.com (AMZN) Misses Q3 EPS by 26c, Offers Q4 Guidance
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Leerink Partners maintained an Outperform rating on TeamHealth Holdings (NYSE: TMH), and cut the price target to $40.00 (from $56.00), following the company's 2Q earnings report and management meetings. The company reported a soft 2Q miss on both revenue and EBITDA. Management remains optimistic on the potential for cross-selling synergies from IPC and even the realization of some BPCI synergies by year-end.
Analyst Ana Gupte commented, "We are lowering our PT to $40 for TMH after a weak 2Q and our meetings with Management, Mike Snow (CEO) and David Jones (CFO), in Nashville on Aug. 17, noting risks to 2016 EBITDA achievability across a) 2Q miss and guide-down, b) Slower turnaround of IPC legacy business, and c) leverage ratio that could hamper M&A."
Shares of Team Health closed at $34.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rosenblatt Upgrades NETGEAR (NTGR) to Buy
- Jefferies Cuts Price Target on Essendant (ESND) to $18 Following EPS Miss
- Jefferies Raises Price Target on General Dynamics (GD) Following 3Q
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!